The fund now owns 116,661 of the company stock, after purchasing an additional 43 555 shares over the past period. Pacer Advisors Inc. held PetMed Express shares worth $1,895,000 at the time of its latest SEC filing.
Recently, other institutional investors have also bought and sold shares in the company. Aspire Private Capital LLC increased their stake in PetMed Express shares by 321.3% during the fourth quarter. Aspire Private Capital LLC owns 1,323 of the company’s stock, worth $23,408,268,000. This is after adding 1,009 additional shares. Captrust Financial Advisors increased its stake in PetMed Express in the first quarter by 72.5%. Captrust Financial Advisors owns 1,570 of the company’s shares valued at $41,000, after purchasing an additional 660 during the period. Quantbot Technologies LP increased their holdings in PetMed Express in the second quarter by 455.7%. Quantbot Technologies LP owns 2,206 of the company’s shares worth $43,000, after acquiring 1,809 additional shares during the last quarter. Point72 Hong Kong Ltd increased its position in PetMed Express during the second quarter by 2,023.8%. Point72 Hong Kong Ltd owns now 3,122 shares worth $62,000, after adding 2,975 more shares over the period. US Bancorp DE increased its holdings of PetMed Express during the first three months by 319.1%. US Bancorp DE owns now 3,751 shares valued at $97,000, after buying an additional 2,856 in the last quarter. During Monday's midday trading, the stock fell $0.17 to $14.79. Stock of the company traded at 565,964 versus its average of 430 412. The company's market cap is $313.10m, with a P/E of 739.87. It also has a beta value of 0.63. PetMed Express, Inc.'s 12-month low is $14.05, and its 12-month high is $24.01. The 50-day simple moving median is $15.25, and the 200-day simple moving median is $17.52.
The company released its last earnings report on Monday, 22nd May. The company's ($0.25) per-share earnings for the quarter fell short of analysts' expectations ($0.14) by $0.39. Revenue was $62.41m during the quarter compared with analysts' expectations at $69.93m. PetMed Express' return on equity was 4.90%, and its net margin was 0.09%. In the same time period last year the company earned $0.30 per share. Analysts predict PetMed Express, Inc. to post an average of 0.55 earnings per shares for the current fiscal.
PetMed Express Announces Dividend
Recently, the business announced a quarterly distribution that will be paid out on Monday, 12th June. Dividends will be paid to shareholders who were in the record books on Tuesday, 6th June. On an annualized base, this is a dividend of $1.20 and yields 8.11%. The ex-dividend day is Monday, 6th June. PetMed Express has a dividend payout ratio of 6,003.00%.
Analyst Upgrades and downgrades
Recent research has been conducted by several analysts on the PETS share price. Lake Street Capital began covering shares of PetMed Express on Thursday, 25th May in a research note. They assigned a buy' rating to the company and set a price target of $20.00. In a research report published on Thursday 18th May, PetMed Express was first covered. The stock was given a rating of 'hold'.
PetMed Express, Inc. is a company that sells prescription and nonprescription pet medication, health products, and supplies to dogs and cats. Non-prescription products include products for flea and tick prevention, joint and bone care, vitamins, treats and nutritional supplements.
MarketBeat.com offers a FREE daily email newsletter